Med Tech Gurus

Time Is Lives

38:34

In rare disease, time isn't money—it's lives.

In this episode of Med Tech Gurus, we sit down with Dr. Rob Freishtat, physician-scientist, former President and Co-Founder of Uncommon Cures, and board member of the Foundation for mRNA Medicines, to explore how clinical trial design is being rewritten for rare and ultra-rare conditions.

Traditional randomized, placebo-controlled trials—largely…